| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Nov 2025 | 3 Nov 2025 |
| Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve the un-audited financial results for the quarter and half year ended 30th September, 2025. The Board of Directors at its meeting held today, have inter alia, transacted the following items of businesses: a) Approved the Unaudited Financial Results for the Quarter and Half year ended 30th September, 2025 along with the Limited Review Report issued by M/s. GMJ & Co., Chartered Accountants which are attached herewith. b) The Board on the recommendation of the Nomination & Remuneration Committee, has approved the appointment of Mr. Rajneesh Anand (DIN: 00134856) as an Additional Non-Executive Non-Independent Director of the Company for a period of 5 (Five) years with effect from 10th November, 2025 subject to the approval of members. Further, the composition of Stakeholders Relationship Committee (SRC) and Corporate Social Responsibility (CSR) Committee of the Company have been reconstituted with the induction of Mr. Rajneesh Anand with effect from 10th November 2025 (As Per Bse Announcement dated on 10/11/2025) | ||
| Board Meeting | 1 Aug 2025 | 26 Jul 2025 |
| Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve unaudited financial results for the quarter ended 30th June 2025 Please refer to the attachment. Please refer to the attachment. (As Per BSE Announcement Dated on :01.08.2025) | ||
| Board Meeting | 13 Jun 2025 | 13 Jun 2025 |
| Please refer to the attachment. | ||
| Board Meeting | 20 May 2025 | 15 May 2025 |
| Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve audited financial results for the quarter and year ended 31st March 2025 The Board of Directors at its meeting held today, have inter alia, transacted the following items of business and taken the decisions as under: 1. Approved the Audited Financial Results for the quarter and year ended 31st March, 2025. A copy of Audited Financial Results for the quarter and year ended 31st March, 2025 is attached herewith. 2. Recommended final dividend of Re. 0.67 i.e. @ 67% per equity share having face value of Re.1/- each aggregating to Re.7,30,06,728 for the Financial Year ended 31st March, 2025. The payment is subject to the approval of shareholders at the ensuing Annual General Meeting. Kindly refer attachment for further details Read less.. (As Per BSE Announcement Dated on :20.05.2025) | ||
| Board Meeting | 14 Feb 2025 | 7 Feb 2025 |
| GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the Unaudited financial results and Limited Review Report for the Quarter and Nine months ended 31st December, 2024. Please refer to the attachment. (As Per BSE Announcement Dated on 14.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.